Global Frontotemporal Disorders Treatment Market Size study & Forecast, by Drug Class, By Disease Indication, By Distribution Channel, and Regional Analysis, 2023-2030

Description

List of Tables

Global Frontotemporal Disorders Treatment Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Frontotemporal disorders (FTD) are also referred to as frontotemporal dementia or frontotemporal degeneration disease, which is caused due to the damage of neurons present in the frontal and temporal lobes of the brain. This disorder includes a major loss of thinking abilities that affects a person's ability to carry out their daily activities like working, driving, and preparing meals. Also, it encompasses symptoms such as emotional problems, difficulty with work, unusual behaviors, trouble communicating, or difficulty with walking. The rising funding by the government, as well as non-government organizations, increasing expenditure on healthcare treatments, growing awareness regarding treatment availability, and increasing geriatric population, are the major factors that are augmenting the market demand across the globe.

In addition, the increasing incidences of dementia and other frontotemporal disorders among the population are playing a significant role that is propelling the market demand at a considerable rate.

According to Alzheimer's Disease International (ADI), in 2020, it was estimated that there were more than 55 million people worldwide suffering from dementia. Also, this number is anticipated to get double every 20 years, which is projected to reach 78 million by 2030 and 139 million by 2050. Thus, these aforementioned factors are propelling the growth of the Frontotemporal Disorders Treatment Market during the estimated period. Furthermore, the rising emphasis on research and development activities, as well as the increasing drug approvals present various lucrative opportunities over the forecasting years. For instance, in November 2022, the U.S. Food and Drug Administration (FDA) launched its Rare Neurodegenerative Disease Grant Program after the passing Accelerating Access to Critical Therapies for ALS Act. Through this initiative, private and public organizations are able to receive grants and contracts to help with the costs of conducting research and development to find a cure for ALS and other rare neurodegenerative diseases that affect both children and adults. Such activities are anticipated to have a favorable impact on the dynamics of the market for frontotemporal disorders treatment. However, the unavailability of skilled professionals and the stringent government regulations are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Frontotemporal Disorders Treatment Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing prevalence of frontotemporal disorders, the presence of well-established healthcare facilities and advances in research activities. As per the Association for Frontotemporal Degeneration, more than 60,000 Americans are estimated to be living with FTD, and the number is projected to double by 2050. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising cases of target disorders, increasing aging population, high unmet medical needs, and increasing healthcare expenditure are significantly propelling the market demand across the region.

Major market players included in this report are:

Pfizer Inc.
Johnson & Johnson
Sanofi S.A.
Eli Lilly and Company
GlaxoSmithKline Plc.
Novartis AG
Mylan N.V.
Merck & Company, Inc.
AstraZeneca plc.
Allergen plc

Recent Developments in the Market:

In April 2022, the US FDA approved Lupin Ltd to put its generic version of the antidepressant medicine Desvenlafaxine extended-release tablets on the market.
In December 2021, the US FDA authorized Caplyta (lumateperone) for the treatment of adult bipolar depression. The only medication authorized by the FDA for the treatment of depressive symptoms resulting from bipolar I or bipolar II disorder in adults as monotherapy or adjunctive therapy with either valproate or lithium is Caplyta, an atypical antipsychotic from the biopharmaceutical company Intra-Cellular Therapies.

Global Frontotemporal Disorders Treatment Market Report Scope:

Historical Data: 2020 - 2021
Base Year for Estimation: 2022
Forecast period: 2023-2030
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Drug Class, Disease Indication, Distribution Channel, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class:

Cognitive Enhancers
Antipsychotics
Antidepressants
CNS Stimulants
Other Drug Classes

By Disease Indication:

Frontotemporal Dementia
Primary Progressive Aphasia
Movement Disorders

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Frontotemporal Disorders Treatment Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Frontotemporal Disorders Treatment Market, by Drug Class, 2020-2030 (USD Billion)
- 1.2.3. Frontotemporal Disorders Treatment Market, by Disease Indication, 2020-2030 (USD Billion)
- 1.2.4. Frontotemporal Disorders Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Frontotemporal Disorders Treatment Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Frontotemporal Disorders Treatment Market Dynamics

3.1. Frontotemporal Disorders Treatment Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidences of dementia and other frontotemporal disorders
  - 3.1.1.2. Rising funding by the government as well as non-government organizations
- 3.1.2. Market Challenges
  - 3.1.2.1. Unavailability of skilled professionals
  - 3.1.2.2. Stringent government regulations
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising emphasis on research and development activities
  - 3.1.3.2. Increasing drug approvals

Chapter 4. Global Frontotemporal Disorders Treatment Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Frontotemporal Disorders Treatment Market, by Drug Class

5.1. Market Snapshot
5.2. Global Frontotemporal Disorders Treatment Market by Drug Class, Performance - Potential Analysis
5.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
- 5.4.1. Cognitive Enhancers
- 5.4.2. Antipsychotics
- 5.4.3. Antidepressants
- 5.4.4. CNS Stimulants
- 5.4.5. Other Drug Classes

Chapter 6. Global Frontotemporal Disorders Treatment Market, by Disease Indication

6.1. Market Snapshot
6.2. Global Frontotemporal Disorders Treatment Market by Disease Indication, Performance - Potential Analysis
6.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Billion)
6.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
- 6.4.1. Frontotemporal Dementia
- 6.4.2. Primary Progressive Aphasia
- 6.4.3. Movement Disorders

Chapter 7. Global Frontotemporal Disorders Treatment Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Frontotemporal Disorders Treatment Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
- 7.4.1. Hospital Pharmacies
- 7.4.2. Retail Pharmacies
- 7.4.3. Online Pharmacies

Chapter 8. Global Frontotemporal Disorders Treatment Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Frontotemporal Disorders Treatment Market, Regional Market Snapshot
8.4. North America Frontotemporal Disorders Treatment Market
- 8.4.1. U.S. Frontotemporal Disorders Treatment Market
  - 8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Disease Indication breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Frontotemporal Disorders Treatment Market
8.5. Europe Frontotemporal Disorders Treatment Market Snapshot
- 8.5.1. U.K. Frontotemporal Disorders Treatment Market
- 8.5.2. Germany Frontotemporal Disorders Treatment Market
- 8.5.3. France Frontotemporal Disorders Treatment Market
- 8.5.4. Spain Frontotemporal Disorders Treatment Market
- 8.5.5. Italy Frontotemporal Disorders Treatment Market
- 8.5.6. Rest of Europe Frontotemporal Disorders Treatment Market
8.6. Asia-Pacific Frontotemporal Disorders Treatment Market Snapshot
- 8.6.1. China Frontotemporal Disorders Treatment Market
- 8.6.2. India Frontotemporal Disorders Treatment Market
- 8.6.3. Japan Frontotemporal Disorders Treatment Market
- 8.6.4. Australia Frontotemporal Disorders Treatment Market
- 8.6.5. South Korea Frontotemporal Disorders Treatment Market
- 8.6.6. Rest of Asia Pacific Frontotemporal Disorders Treatment Market
8.7. Latin America Frontotemporal Disorders Treatment Market Snapshot
- 8.7.1. Brazil Frontotemporal Disorders Treatment Market
- 8.7.2. Mexico Frontotemporal Disorders Treatment Market
8.8. Middle East & Africa Frontotemporal Disorders Treatment Market
- 8.8.1. Saudi Arabia Frontotemporal Disorders Treatment Market
- 8.8.2. South Africa Frontotemporal Disorders Treatment Market
- 8.8.3. Rest of Middle East & Africa Frontotemporal Disorders Treatment Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Pfizer Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Johnson & Johnson
- 9.3.3. Sanofi S.A.
- 9.3.4. Eli Lilly and Company
- 9.3.5. GlaxoSmithKline Plc.
- 9.3.6. Novartis AG
- 9.3.7. Mylan N.V.
- 9.3.8. Merck & Company, Inc.
- 9.3.9. AstraZeneca plc.
- 9.3.10. Allergen plc

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Frontotemporal Disorders Treatment Market, report scope
TABLE 2. Global Frontotemporal Disorders Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Frontotemporal Disorders Treatment Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 4. Global Frontotemporal Disorders Treatment Market estimates & forecasts by Disease Indication 2020-2030 (USD Billion)
TABLE 5. Global Frontotemporal Disorders Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Frontotemporal Disorders Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Frontotemporal Disorders Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Frontotemporal Disorders Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Frontotemporal Disorders Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Frontotemporal Disorders Treatment Market
TABLE 71. List of primary sources, used in the study of global Frontotemporal Disorders Treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Frontotemporal Disorders Treatment Market, research methodology
FIG 2. Global Frontotemporal Disorders Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Frontotemporal Disorders Treatment Market, key trends 2022
FIG 5. Global Frontotemporal Disorders Treatment Market, growth prospects 2023-2030
FIG 6. Global Frontotemporal Disorders Treatment Market, porters 5 force model
FIG 7. Global Frontotemporal Disorders Treatment Market, pest analysis
FIG 8. Global Frontotemporal Disorders Treatment Market, value chain analysis
FIG 9. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Frontotemporal Disorders Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Frontotemporal Disorders Treatment Market, regional snapshot 2020 & 2030
FIG 15. North America Frontotemporal Disorders Treatment Market 2020 & 2030 (USD Billion)
FIG 16. Europe Frontotemporal Disorders Treatment Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Frontotemporal Disorders Treatment Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Conventional and Alternative Pain Treatment Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Frontotemporal Disorders Treatment Market 2020 & 2030 (USD Billion)